RecruitingMajor Depressive Disorder
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Eligible age
18+ yrs
Accepts
All genders
Locations
15 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study will evaluate the long-term safety and tolerability of NBI-1065845 as an adjunctive treatment in participants with MDD.
Sponsor: Neurocrine Biosciences
Where it's recruiting
Alabama
Huntsville
Arkansas
Bryant · Little Rock
California
Glendale · Los Angeles · Oceanside · Orange …
Connecticut
Cromwell · Farmington
Florida
Hollywood · Maitland · Miami · Miami Gardens …
Georgia
Atlanta
Maryland
Gaithersburg
Massachusetts
Boston · Watertown
Missouri
O'Fallon · Saint Charles
New York
Cedarhurst · Mount Kisco · New York · The Bronx
Ohio
Avon Lake
Oklahoma
Edmond · Oklahoma City
Source: ClinicalTrials.gov · NCT06966401 · last updated 2026-06-22